The Tata Group, one of the largest and most respected conglomerates in the world, is Indigene's strategic partner and investor. Indigene is leveraging the Tata Group's credibility, brand equity, and ability to nurture growing companies to accelerate our business growth.

Pictured (L to R): Mr. Ratan N. Tata, Tata Industries (TIL); Dr. M. Vaman Rao, Chairman and CEO, Indigene Pharmaceuticals; and Dr. R. A. Mashelkar, F.R.S., Board Member of Indigene Pharmaceuticals

Indigene has established a strategic partner ship with Max Zeller Söhne, AG in Switzerland to support and accelerate our product development and manufacturing capabilities of some of our CHC products. Indigene's CHC products are developed and manufactured as per qualified, compliant, and Swiss Medic approved current Good Manufacturing Practices (cGMP).